These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29862949)

  • 1. Impact of a national nutritional support programme on loss to follow-up after tuberculosis diagnosis in Kenya.
    Mansour O; Masini EO; Kim BJ; Kamene M; Githiomi MM; Hanson CL
    Int J Tuberc Lung Dis; 2018 Jun; 22(6):649-654. PubMed ID: 29862949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss to follow-up among patients diagnosed with spinal tuberculosis at a tertiary hospital in Western Cape Province, South Africa: A retrospective cohort study.
    Mann TN; Davis JH; Dyers R
    S Afr Med J; 2020 Mar; 110(4):284-290. PubMed ID: 32657739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss to follow-up among adolescents with tuberculosis in Gaborone, Botswana.
    Enane LA; Lowenthal ED; Arscott-Mills T; Matlhare M; Smallcomb LS; Kgwaadira B; Coffin SE; Steenhoff AP
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1320-1325. PubMed ID: 27725042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Survival Analysis to Identify Risk Factors for Treatment Interruption among New and Retreatment Tuberculosis Patients in Kenya.
    Masini EO; Mansour O; Speer CE; Addona V; Hanson CL; Sitienei JK; Kipruto HK; Githiomi MM; Mungai BN
    PLoS One; 2016; 11(10):e0164172. PubMed ID: 27706230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K; Saini V; Dhillon R; Agarwal P
    Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with loss to follow-up from tuberculosis treatment in Tajikistan: a case-control study.
    Wohlleben J; Makhmudova M; Saidova F; Azamova S; Mergenthaler C; Verver S
    BMC Infect Dis; 2017 Aug; 17(1):543. PubMed ID: 28778187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects.
    Soedarsono S; Mertaniasih NM; Kusmiati T; Permatasari A; Juliasih NN; Hadi C; Alfian IN
    BMC Pulm Med; 2021 Nov; 21(1):360. PubMed ID: 34758794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands.
    Gafar F; Van't Boveneind-Vrubleuskaya N; Akkerman OW; Wilffert B; Alffenaar JC
    Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31515410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.
    Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW
    BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of quantitative and qualitative methods in investigating risk factors for lost to follow-up for tuberculosis treatment in Japan - Are physicians and nurses at a particular risk?
    Kawatsu L; Uchimura K; Ohkado A; Kato S
    PLoS One; 2018; 13(6):e0198075. PubMed ID: 29906287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes of drug-resistant tuberculosis patients in Kenya.
    Mibei DJ; Kiarie JW; Wairia A; Kamene M; Okumu ME
    Int J Tuberc Lung Dis; 2016 Nov; 20(11):1477-1482. PubMed ID: 27776588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Loss to Follow-Up among Men with Tuberculosis in Puducherry and Tamil Nadu, India.
    Zhou TJ; Lakshminarayanan S; Sarkar S; Knudsen S; Horsburgh CR; Muthaiah M; Kan CK; Salgame P; Ellner JJ; Roy G; Jenkins HE; Hochberg NS
    Am J Trop Med Hyg; 2020 Sep; 103(3):1050-1056. PubMed ID: 32618243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with 36-month loss to follow-up and mortality outcomes among HIV-infected adults on antiretroviral therapy in Central Kenya.
    Wekesa P; McLigeyo A; Owuor K; Mwangi J; Nganga E; Masamaro K
    BMC Public Health; 2020 Mar; 20(1):328. PubMed ID: 32171279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa.
    Berry KM; Rodriguez CA; Berhanu RH; Ismail N; Mvusi L; Long L; Evans D
    BMC Public Health; 2019 Jul; 19(1):973. PubMed ID: 31331311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High treatment success rate among multidrug-resistant tuberculosis patients in Myanmar, 2012-2014: a retrospective cohort study.
    Thu MK; Kumar AMV; Soe KT; Saw S; Thein S; Mynit Z; Maung HMW; Aung ST
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):410-417. PubMed ID: 29351672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hidden loss to follow-up among tuberculosis patients managed by public-private mix institutions in South Korea.
    Kim HW; Park S; Min J; Sun J; Shin AY; Ha JH; Park JS; Lee SS; Lipman M; Abubakar I; Stagg HR; Kim JS
    Sci Rep; 2022 Jul; 12(1):12362. PubMed ID: 35859107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting.
    Mohr E; Daniels J; Beko B; Isaakidis P; Cox V; Steele SJ; Muller O; Snyman L; De Azevedo V; Shroufi A; Trivino Duran L; Hughes J
    PLoS One; 2017; 12(5):e0178054. PubMed ID: 28542441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.
    Alipanah N; Jarlsberg L; Miller C; Linh NN; Falzon D; Jaramillo E; Nahid P
    PLoS Med; 2018 Jul; 15(7):e1002595. PubMed ID: 29969463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.